Immunotargeting of Nanocrystals by SpyCatcher Conjugation of Engineered Antibodies.

Pedroso, Cassio C S; Mann, Victor R; Zuberbühler, Kathrin; Bohn, Markus-Frederik; Yu, Jessica; Altoe, Virginia; Craik, Charles S; Cohen, Bruce E

Pedroso, Cassio C S; Mann, Victor R; Zuberbühler, Kathrin; Bohn, Markus-Frederik; Yu, Jessica; Altoe, Virginia; Craik, Charles S; Cohen, Bruce E.

Afiliação

Zuberbühler K; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California 94143, United States.
Bohn MF; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California 94143, United States.
Craik CS; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California 94143, United States.

ACS Nano ; 15(11): 18374-18384, 2021 11 23.

Article em En | MEDLINE | ID: mdl-34694776

Assuntos

Nanopartículas; Pontos Quânticos; Humanos; Receptores de Ativador de Plasminogênio Tipo Uroquinase/metabolismo; Anticorpos/metabolismo; Membrana Celular/metabolismo; Ativador de Plasminogênio Tipo Uroquinase/metabolismo

Palavras-chave

antibodies; bioconjugation; cancer cells; quantum dots; receptor trafficking; uPAR; upconverting nanoparticles

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pontos Quânticos / Nanopartículas Limite: Humans Idioma: En Revista: ACS Nano Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google